Loading...

Jagsonpal Pharmaceuticals Limited

JAGSNPHARM.NS•NSE
Healthcare
Drug Manufacturers - Specialty & Generic
₹207.05
₹-3.32(-1.58%)
Indian Market opens in 14h 33m

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) Stock Overview

Explore Jagsonpal Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14.3B
P/E Ratio34.64
EPS (TTM)$6.31
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$173.77
3 Months$161.55
1 Year Target$268.57

JAGSNPHARM.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 74.43, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $268.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 34.64 and a market capitalization of 14.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.19%
5-Day Change
2.98%
1-Month Change
11.70%
3-Month Change
22.08%
6-Month Change
-1.73%
Year-to-Date (YTD) Change
10.52%
1-Year Change
-14.82%
3-Year Change
54.93%
5-Year Change
454.06%
All-Time (Max) Change
5029.40%

Contact Information

https://www.jagsonpal.com
91 11 4618 1100
T-210 J, Shahpur Jat, Gurugram, NaN, 110049

Company Facts

10,250 Employees
IPO DateJul 1, 2002
CountryIN
Actively Trading

Frequently Asked Questions